Aug. 14 Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
May. 15 Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Mar. 26 Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
Jan. 23 Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil CI
Dec. 10 Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors CI
Nov. 14 Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-10-21 Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer CI
25-10-21 SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform CI
25-08-21 Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-15 Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-26 Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-16 Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million. CI
24-11-14 Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
Manager TitleAgeSince
Chief Executive Officer - 2021-11-22
Investor Relations Contact 40 2021-11-22
Director TitleAgeSince
Chairman - 2021-11-22
Director/Board Member 58 2021-11-22
Director/Board Member 50 2018-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
1/10/25 Buy 1,644,236 0.1665%
12/4/24 Sell 15,405,639 1.5600%
12/4/24 Buy 15,405,639 1.5600%

Financials

2024 2025
Net sales 10.97B 1.84B 1.68B 1.55B 1.41B 2.64B 171B 2.78B 18.84B 7.49B 93.28B 6.92B 6.77B 293B 12.48B 2.1B 1.91B 1.76B 1.6B 3B 194B 3.16B 21.42B 8.51B 106B 7.87B 7.7B 333B
Net income 117M 19.71M 17.96M 16.54M 15.05M 28.23M 1.83B 29.67M 201M 80.03M 997M 73.97M 72.41M 3.13B 571M 96.05M 87.49M 80.61M 73.33M 138M 8.89B 145M 981M 390M 4.86B 360M 353M 15.25B
Net Debt - -
Projected Income Statement - Annual - Eurofarma Laboratórios S.A.
  1. Stock Market
  2. Stocks
  3. EUFA3 Stock